You have 9 free searches left this month | for more free features.

Portal systemic shunting

Showing 26 - 50 of 9,620

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Phenylketonuria Trial in Pittsburgh (radiation, procedure, drug, other, behavioral, diagnostic test)

Recruiting
  • Phenylketonuria
  • Preparative Radiation Therapy
  • +6 more
  • Pittsburgh, Pennsylvania
  • +1 more
Jan 9, 2023

Pre-operative EUS Guided and Intra-operative Direct Portal Vein

Not yet recruiting
  • Liver Cirrhosis
  • EUS Portal pressure measurement
  • (no location specified)
Nov 1, 2023

Cirrhosis, Portal Hypertension, Exercise Trial (Exercise, nutritional therapy)

Completed
  • Cirrhosis
  • +2 more
  • Exercise
  • nutritional therapy
  • (no location specified)
Aug 31, 2022

Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Seoul (PBT and atezolizumab/bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Portal Vein Thrombosis
  • PBT and atezolizumab/bevacizumab
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 15, 2022

Living Donor Liver Transplantation, Norepinephrine Bolus, Postperfusion Syndrome Trial in Mansoura (Norepinephrine boluses)

Completed
  • Living Donor Liver Transplantation
  • +2 more
  • Norepinephrine boluses
  • Mansoura, Dakahlia, Egypt
    Mansoura University, Gastrointestinal Surgery Center, Liver Tran
Dec 20, 2022

Liver Cirrhosis Trial in New Delhi (Carvedilol, Pentoxifylline)

Not yet recruiting
  • Liver Cirrhosis
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences.
Sep 16, 2023

Chronic Portal Vein Thrombosis in Children

Not yet recruiting
  • Portal Vein Thrombosis
  • endoscopy
  • (no location specified)
Nov 3, 2023

Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

Recruiting
  • Cirrhosis
  • +3 more
  • Yangzhou, Jiangsu, China
    Clinical Medical College of Yangzhou University
Mar 19, 2022

Persistent Pulmonary Hypertension of the Newborn, Echocardiography, Respiratory Disease Trial (Nebulized nitroglycerine as

Not yet recruiting
  • Persistent Pulmonary Hypertension of the Newborn
  • +2 more
  • Nebulized nitroglycerine as adjunctive therapy
  • conventional therapy for PPHN
  • (no location specified)
Feb 23, 2023

Hepatocellular Carcinoma, Portal Vein Tumour Thrombosis Trial in Canada (Neoadjuvant)

Recruiting
  • Hepatocellular Carcinoma
  • Portal Vein Tumour Thrombosis
  • Neoadjuvant
  • Calgary, Alberta, Canada
  • +6 more
Oct 18, 2022

Portal Hypertension Trial in New Delhi (Carvedilol)

Not yet recruiting
  • Portal Hypertension
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Mar 1, 2023

Portal Hypertension, Variceal Hemorrhage, Ulcer Hemorrhage Trial in Alexandria (Vonoprazan fumarate (Vonaspire), Pantoprazole

Completed
  • Portal Hypertension
  • +2 more
  • Vonoprazan fumarate (Vonaspire)
  • +2 more
  • Alexandria, Egypt
    Alexandria Main University Hospital
Nov 15, 2022

Health Technology Trial in New Haven (Email, Text, Patient Portal Message)

Not yet recruiting
  • Health Technology
  • Email
  • +2 more
  • New Haven, Connecticut
  • +1 more
Aug 10, 2023

VExUS Score for Prediction of Acute Renal Failure in Cardiac

Recruiting
  • Renal Failure
  • +3 more
    • Grenoble, France
      University Hospital Grenoble
    Jan 20, 2023

    Multimodal Ultrasound and Portal Hypertension

    Recruiting
    • Portal Hypertension
      • Roma, Italy
        Fondazione Policlinico Gemelli IRCCS
      Mar 16, 2023

      Cirrhosis, Portal Hypertension Trial in Alicante (EUS-PPG and HVPG)

      Recruiting
      • Cirrhosis
      • Portal Hypertension
      • EUS-PPG and HVPG
      • Alicante, Spain
        Unidad de Endoscopia. Hospital General Universitario de Alicante
      Jan 17, 2023

      Pseudotumor Cerebri, Idiopathic Intracranial Hypertension (IIH) Trial in Phoenix, Seattle (Dural Venous Sinus Stenting,

      Recruiting
      • Pseudotumor Cerebri
      • Idiopathic Intracranial Hypertension (IIH)
      • Dural Venous Sinus Stenting
      • Cerebrospinal Fluid Shunting
      • Phoenix, Arizona
      • +1 more
      Jan 17, 2023

      SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing

      Recruiting
      • Lupus Erythematosus, Systemic
        • Aichi, Japan
        • +93 more
        Jan 24, 2023

        Idiopathic Normal Pressure Hydrocephalus (INPH) Trial in Canada, Sweden, United States (programmable CSF shunt valve)

        Recruiting
        • Idiopathic Normal Pressure Hydrocephalus (INPH)
        • programmable CSF shunt valve
        • Davis, California
        • +15 more
        Aug 12, 2022

        Systemic Lupus Erythematosus Trial (Belimumab, Standard of care)

        Not yet recruiting
        • Systemic Lupus Erythematosus
        • Belimumab
        • Standard of care
        • (no location specified)
        Jun 14, 2023

        Liver and Spleen Stiffness Measured by TE and 2D-SWE for

        Recruiting
        • Liver Cirrhosis
        • +2 more
        • Diagnostic Test: Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
        • Zhuhai, Guangdong, China
          The Fifth Affiliated Hospital, Sun Yat-sen University
        Nov 19, 2023

        BA - Biliary Atresia Trial in Aswan (hepato-portoentostomy)

        Completed
        • BA - Biliary Atresia
        • hepato-portoentostomy
        • Aswan, Sahary, Egypt
          Aswan university
        Jun 22, 2023

        Idiopathic Normal Pressure Hydrocephalus (INPH) Trial in Canada, Sweden, United States (programmable CSF shunt valve)

        Completed
        • Idiopathic Normal Pressure Hydrocephalus (INPH)
        • programmable CSF shunt valve
        • Baltimore, Maryland
        • +6 more
        Jul 29, 2022

        Cirrhosis Due to Hepatitis B, Cirrhosis Due to Hepatitis C, Gastroesophageal Varices Trial in Tianjin (Carvedilol, Berberine)

        Not yet recruiting
        • Cirrhosis Due to Hepatitis B
        • +2 more
        • Tianjin, Tianjin, China
          Tianjin Second People's Hospital
        Oct 18, 2021

        Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open

        Not yet recruiting
        • Systemic Sclerosis
        • Scleroderma
        • Anifrolumab (blinded)
        • +2 more
        • Birmingham, Alabama
        • +130 more
        Jun 22, 2023